DNAnexus Developing NGS Workflows with Geisinger, UCSF | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – DNAnexus today announced deals with the Geisinger Health System and the University of California, San Francisco to develop clinically relevant workflows.

The workflows will provide new information for the use of DNA sequencing in clinical applications, the Mountain View, Calif.-based data management and analysis firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.